Similarly, Desai et al. found that VAF of more than 1% in mutations of IDH2, TP53, DNMT3A, TET2 and spliceosome genes was associated with increased risk of AML development, though VAF > 10% were associated with even greater risk [54]. This evidence concerns the gene TET2 and acute myeloid leukemia.